David E Elliott1, Joel V Weinstock. 1. Division of Gastroenterology, University of Iowa Carver College of Medicine and VAMC, Iowa City, Iowa 52242, USA. david-elliott@uiowa.edu
Abstract
PURPOSE OF REVIEW: There is something about living in an industrialized country that dramatically increases the risk of acquiring inflammatory bowel disease (IBD). Loss of routine exposure to parasitic worms (helminths), due to modern highly hygienic life styles, likely contributes to this risk. This article reviews current understanding on how helminths influence intestinal inflammation and mucosal immune responses. RECENT FINDINGS: IBD emerges in populations as regions develop socioeconomically and lose exposure to previously ubiquitous helminthic infections. Helminthic infections provided strong selective pressure for the dissemination of gene variants, many of which predispose to development of IBD. In animal models of IBD, helminth colonization suppresses intestinal inflammation through multiple mechanisms including induction of innate and adaptive regulatory circuits. Trials using helminths like hookworm (Necator americanus) or porcine whipworm (Trichuris suis) show that they are safe and may be effective therapies for the control of the aberrant intestinal inflammation seen in Crohn's disease and ulcerative colitis. SUMMARY: Evidence is accumulating that highly hygienic living conditions create risk for developing immune-mediated disease such as IBD. To live in their host, helminths have developed the ability to activate cells of innate and adaptive immunity that suppress inflammation. Therapeutic trials using helminths are in progress.
PURPOSE OF REVIEW: There is something about living in an industrialized country that dramatically increases the risk of acquiring inflammatory bowel disease (IBD). Loss of routine exposure to parasitic worms (helminths), due to modern highly hygienic life styles, likely contributes to this risk. This article reviews current understanding on how helminths influence intestinal inflammation and mucosal immune responses. RECENT FINDINGS: IBD emerges in populations as regions develop socioeconomically and lose exposure to previously ubiquitous helminthic infections. Helminthic infections provided strong selective pressure for the dissemination of gene variants, many of which predispose to development of IBD. In animal models of IBD, helminth colonization suppresses intestinal inflammation through multiple mechanisms including induction of innate and adaptive regulatory circuits. Trials using helminths like hookworm (Necator americanus) or porcine whipworm (Trichuris suis) show that they are safe and may be effective therapies for the control of the aberrant intestinal inflammation seen in Crohn's disease and ulcerative colitis. SUMMARY: Evidence is accumulating that highly hygienic living conditions create risk for developing immune-mediated disease such as IBD. To live in their host, helminths have developed the ability to activate cells of innate and adaptive immunity that suppress inflammation. Therapeutic trials using helminths are in progress.
Authors: Dong Hyuk Shin; Dong Hyun Sinn; Young-Ho Kim; Jin Yong Kim; Dong Kyung Chang; Eun Jin Kim; Ho Yoel Ryu; Han Ul Song; Il Young Kim; Do Hyoung Kim; Yun Young Kim; Suk Hun Kim; Yu Bin Seo; Ki Won Hwang; Jae J Kim Journal: Dig Dis Sci Date: 2010-09-16 Impact factor: 3.199
Authors: David E Elliott; Ahmed Metwali; John Leung; Tommy Setiawan; Arthur M Blum; M Nedim Ince; Lindsey E Bazzone; Miguel J Stadecker; Joseph F Urban; Joel V Weinstock Journal: J Immunol Date: 2008-08-15 Impact factor: 5.422
Authors: Henry J McSorley; Soraya Gaze; James Daveson; Dianne Jones; Robert P Anderson; Andrew Clouston; Nathalie E Ruyssers; Richard Speare; James S McCarthy; Christian R Engwerda; John Croese; Alex Loukas Journal: PLoS One Date: 2011-09-16 Impact factor: 3.240
Authors: Peter Vogel; Laura Janke; David M Gravano; Meifen Lu; Deepali V Sawant; Dorothy Bush; E Shuyu; Dario A A Vignali; Asha Pillai; Jerold E Rehg Journal: Vet Pathol Date: 2017-05-11 Impact factor: 2.221
Authors: Helton da Costa Santiago; Flávia L Ribeiro-Gomes; Sasisekhar Bennuru; Thomas B Nutman Journal: J Immunol Date: 2014-11-17 Impact factor: 5.422
Authors: Sandeep Chhabra; Shih Chieh Chang; Hai M Nguyen; Redwan Huq; Mark R Tanner; Luz M Londono; Rosendo Estrada; Vikas Dhawan; Satendra Chauhan; Sanjeev K Upadhyay; Mariel Gindin; Peter J Hotez; Jesus G Valenzuela; Biswaranjan Mohanty; James D Swarbrick; Heike Wulff; Shawn P Iadonato; George A Gutman; Christine Beeton; Michael W Pennington; Raymond S Norton; K George Chandy Journal: FASEB J Date: 2014-06-02 Impact factor: 5.191
Authors: David T Rodgers; Mairi A McGrath; Miguel A Pineda; Lamyaa Al-Riyami; Justyna Rzepecka; Felicity Lumb; William Harnett; Margaret M Harnett Journal: Arthritis Rheumatol Date: 2015-04 Impact factor: 10.995